ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

Less can be more: The case for extended dosing intervals in biologic therapy for AD.

Christian VestergaardPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.